Clinical Pharmacology and Pharmacokinetic Properties of Topically Applied Corticosteroids: A Review

Drugs

Volumn 36, Issue 5, 1988, Pages 51-61

  Goa, Karen L ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETAMETHASONE; CORTICOSTEROID; CORTISONE; DEXAMETHASONE; DIFLUCORTOLONE VALERATE; FLUOCORTOLONE; HYDROCORTISONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ADRENAL SUPPRESSION; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG METABOLISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN DEFECT; SKIN DISEASE; STRUCTURE ACTIVITY RELATION; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, TOPICAL; HUMAN;

EID: 0024152914     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198800365-00011     Document Type: Review

References (79)

1. Influence of corticosteroids on connective tissue
2. Bioavailability of topical steroids
3. Mitotic index of psoriatic lesions treated with anthralin, glucocorticosteroid and occlusion only
4. Percutaneous absorption of corticosteroids: age, site, and skin sectioning influences on rates of permeation of hairless mouse skin by hydrocortisone
5. The formation of water soluble steroids bv human skin
6. The effects of new local anti-inflammatory steroids on leucocyte migration and prostanoid liberation in rats
7. Specificity and inhibition of glucocorticoid-induced macrocortin secretion from rat peritoneal macrophages
8. Corticosteroid ointments: comparison by two human bioassays
9. Complications of topical corticosteroid therapy in patients with liver disease
10. Observations on the systemic effects of topical clobetasol propionate
11. Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and Chemotaxis
12. Correlation of the vasoconstriction assay and clinical activity in psoriasis
13. Current dangers and problems in the topical use of steroids
14. Corticosteroid effect on epidermal cell size
15. 14C-hydrocortisone through normal skin: the effect of stripping and occlusion
16. 14C-cortisol in man
17. The effect of corticosteroids on human epidermal mitotic activity
18. Penetrationskinetik von Fluocortolon aus einer Salben und Cremegrundlage
19. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation
20. Kinetics of cutaneous drug penetration
21. Topical glucocorticosteroids
22. Systemic absorption of topical steroids. Metabolic effects as an index of mild hypercortisolism
23. Correlation of the vasoconstrictor assay and clinical activity in psoriasis
24. Induction of glycosuria and hyperglycemia by topical corticosteroid therapy
25. Topical steroids and the pharmacology of inflammation
26. Electron microscope evaluation of collagen fibrils after topical corticosteroid therapy
27. Drug delivery to local subcutaneous structures following topical administration
28. Relative potencies of topical corticosteroid formulations
29. Pharmacokinetic investigation of 17α desoxy-methasone (A 41 304) in rats
30. Stabilization of rat liver lysosomes by new anti-inflammatory steroids in vitro
31. A case of osteoporosis and avascular necrosis of the hips following long-term use of clobetasol propionate ointment
32. Perioral dermatitis and rosacea
33. Proposed mode of action of corticosteroids on the connective tissue
34. Washing of napkin area after repeated use of fluorinated steroid ointment
35. Objective measurement of topically applied corticosteroids
36. Steroid induced atrophy in an animal and human model
37. Steroid addiction
38. Altersbedingte Unterschiede der pharmakologischen Wirkungen von Kortikosteroid-Externa
39. Cutaneous mast cell depletion results from topical corticosteroid usage
40. Effects of topical corticosteroids on human dermis
41. Aggressive topical corticosteroid therapy: a novel approach to mast-cell dependent cutaneous disorders
42. Topical steroids
43. Corticosteroid atrophy in human skin: a study by light scanning and transmission electron microscopy
44. Method for comparing percutaneous absorption of steroids
45. In vivopercutaneous penetration of corticosteroids in man and unresolved problems in their efficacy
46. Methods for the assessment of skin atrophogenicity of topical corticosteroids
47. The action of topical corticosteroids on the epidermal cell cycle
48. Topically applied triamcinolone and macromolecular synthesis by human epidermis
49. A method for the assay of topical corticosteroids
50. Cushing’s syndrome from percutaneous absorption of triamcinolone cream
51. Atrophic striae following topical fluocinolone therapy
52. Percutaneous absorption of betamethasone 17-benzoate measured by radioimmunoassay
53. Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-adrenal axis
54. Psoriasis — its response to dithranol and clobetasol propionate: a comparative study
55. The effect of epicutaneous glucocorticosteroids on human monocyte and neutrophil migration in vivo
56. Mechanisms of steroid hormone action
57. The skin as a drug metabolizing organ
58. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin
59. Percutaneous absorption of topically applied triamcinolone in children
60. Interruption by topical cortisone of leukocytic cycles in acute inflammation in man
61. A new model for human bioassay of topical corticosteroids
62. Inhibition of acid mucopolysaccharide synthesis by hydrocortisone, hydrocortisone-17-butyrate and betamethasone-17-valerate
63. Percutaneous absorption after twenty-five years, or ‘old wine in new wineskins’
64. The effect of topical corticosteroids on the metabolism of dermal collagen
65. Corticosteroid induced atrophy and telangiectasia
66. Mechanisms of glucocorticoid activity
67. Corticosteroid induced atrophy of the epidermis
68. The effect of topically applied compound F in selected dermatoses
69. Verfügbarkeit von Diflucortolon-21-valerat in der menschlichen Hau
70. Biotransformation von Diflucortolonvalerianat in der Haut von Ratte, Meerschweinchen und Mensch
71. Vergleichende Untersuchungen am Menschen zurperkutanen Resorption von Diflucortolon valerianat, Betamethasone-17-valerianat, Beclome-thasondipropionat und Fluocinolonacetonid
72. Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children
73. Existence of reservoirs in the stratum corneum
74. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption
75. In vivopercutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers
76. Steroid atrophy — a histological appraisal
77. Epidermal wound healing in corticosteroid treated skin of the domestic pig
78. Corticosteroid induced atrophy in the skin of the domestic pig
79. The influence of urea on the penetration kinetics of topically applied corticosteroids